Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy

Toshio Doi, Tatsumi Moriya, Yui Fujita, Naoto Minagawa, Masaru Usami, Tomoko Sasaki, Hideharu Abe, Seiji Kishi, Taichi Murakami, Motoshi Ouchi, Go Ichien, Keiichi Yamamoto, Hiroki Ikeda, Yasuhiko Koezuka, Norimichi Takamatsu, Kenji Shima, Michael Mauer, Kojiro Nagai, Tatsuya Tominaga

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Diabetic nephropathy (DN) is the major cause of end-stage kidney disease, but early biomarkers of DN risk are limited. Herein we examine urinary IgG4 and Smad1 as additional early DN biomarkers. We recruited 815 patients with type 2 diabetes; 554 patients fulfilled the criteria of an estimated glomerular filtration rate (EGFR) >60 mL/min and no macroalbuminuria at baseline, with follow-up for 5 years. Patients without macroalbuminuria were also recruited for renal biopsies. Urinary IgG4 and Smad1 were determined by enzyme-linked immunoassays using specific antibodies. The specificity, sensitivity, and reproducibility were confirmed for each assay. Increased urinary IgG4 was significantly associated with lower EGFR. The level of urinary IgG4 also significantly correlated with surface density of peripheral glomerular basement membrane (Sv PGBM/Glom), whereas Smad1 was associated with the degree of mesangial expansion-both classic pathological findings in DN. Baseline EGFR did not differ between any groups; however, increases in both urinary IgG4 and Smad1 levels at baseline significantly predicted later development of EGFR decline in patients without macroalbuminuria. These data suggest that urinary IgG4 and Smad1 at relatively early stages of DN reflect underlying DN lesions and are relevant to later clinical outcomes.

Original languageEnglish (US)
Pages (from-to)986-993
Number of pages8
JournalDiabetes
Volume67
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Diabetic Nephropathies
Immunoglobulin G
Biomarkers
Glomerular Filtration Rate
Kidney
Glomerular Basement Membrane
Immunoenzyme Techniques
Type 2 Diabetes Mellitus
Chronic Kidney Failure
Biopsy
Sensitivity and Specificity
Antibodies

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Doi, T., Moriya, T., Fujita, Y., Minagawa, N., Usami, M., Sasaki, T., ... Tominaga, T. (2018). Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy. Diabetes, 67(5), 986-993. https://doi.org/10.2337/db17-1043

Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy. / Doi, Toshio; Moriya, Tatsumi; Fujita, Yui; Minagawa, Naoto; Usami, Masaru; Sasaki, Tomoko; Abe, Hideharu; Kishi, Seiji; Murakami, Taichi; Ouchi, Motoshi; Ichien, Go; Yamamoto, Keiichi; Ikeda, Hiroki; Koezuka, Yasuhiko; Takamatsu, Norimichi; Shima, Kenji; Mauer, Michael; Nagai, Kojiro; Tominaga, Tatsuya.

In: Diabetes, Vol. 67, No. 5, 01.05.2018, p. 986-993.

Research output: Contribution to journalArticle

Doi, T, Moriya, T, Fujita, Y, Minagawa, N, Usami, M, Sasaki, T, Abe, H, Kishi, S, Murakami, T, Ouchi, M, Ichien, G, Yamamoto, K, Ikeda, H, Koezuka, Y, Takamatsu, N, Shima, K, Mauer, M, Nagai, K & Tominaga, T 2018, 'Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy', Diabetes, vol. 67, no. 5, pp. 986-993. https://doi.org/10.2337/db17-1043
Doi, Toshio ; Moriya, Tatsumi ; Fujita, Yui ; Minagawa, Naoto ; Usami, Masaru ; Sasaki, Tomoko ; Abe, Hideharu ; Kishi, Seiji ; Murakami, Taichi ; Ouchi, Motoshi ; Ichien, Go ; Yamamoto, Keiichi ; Ikeda, Hiroki ; Koezuka, Yasuhiko ; Takamatsu, Norimichi ; Shima, Kenji ; Mauer, Michael ; Nagai, Kojiro ; Tominaga, Tatsuya. / Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy. In: Diabetes. 2018 ; Vol. 67, No. 5. pp. 986-993.
@article{9d626bbefa6245e99d82c8d47f783cd2,
title = "Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy",
abstract = "Diabetic nephropathy (DN) is the major cause of end-stage kidney disease, but early biomarkers of DN risk are limited. Herein we examine urinary IgG4 and Smad1 as additional early DN biomarkers. We recruited 815 patients with type 2 diabetes; 554 patients fulfilled the criteria of an estimated glomerular filtration rate (EGFR) >60 mL/min and no macroalbuminuria at baseline, with follow-up for 5 years. Patients without macroalbuminuria were also recruited for renal biopsies. Urinary IgG4 and Smad1 were determined by enzyme-linked immunoassays using specific antibodies. The specificity, sensitivity, and reproducibility were confirmed for each assay. Increased urinary IgG4 was significantly associated with lower EGFR. The level of urinary IgG4 also significantly correlated with surface density of peripheral glomerular basement membrane (Sv PGBM/Glom), whereas Smad1 was associated with the degree of mesangial expansion-both classic pathological findings in DN. Baseline EGFR did not differ between any groups; however, increases in both urinary IgG4 and Smad1 levels at baseline significantly predicted later development of EGFR decline in patients without macroalbuminuria. These data suggest that urinary IgG4 and Smad1 at relatively early stages of DN reflect underlying DN lesions and are relevant to later clinical outcomes.",
author = "Toshio Doi and Tatsumi Moriya and Yui Fujita and Naoto Minagawa and Masaru Usami and Tomoko Sasaki and Hideharu Abe and Seiji Kishi and Taichi Murakami and Motoshi Ouchi and Go Ichien and Keiichi Yamamoto and Hiroki Ikeda and Yasuhiko Koezuka and Norimichi Takamatsu and Kenji Shima and Michael Mauer and Kojiro Nagai and Tatsuya Tominaga",
year = "2018",
month = "5",
day = "1",
doi = "10.2337/db17-1043",
language = "English (US)",
volume = "67",
pages = "986--993",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Urinary IgG4 and Smad1 are specific biomarkers for renal structural and functional changes in early stages of diabetic nephropathy

AU - Doi, Toshio

AU - Moriya, Tatsumi

AU - Fujita, Yui

AU - Minagawa, Naoto

AU - Usami, Masaru

AU - Sasaki, Tomoko

AU - Abe, Hideharu

AU - Kishi, Seiji

AU - Murakami, Taichi

AU - Ouchi, Motoshi

AU - Ichien, Go

AU - Yamamoto, Keiichi

AU - Ikeda, Hiroki

AU - Koezuka, Yasuhiko

AU - Takamatsu, Norimichi

AU - Shima, Kenji

AU - Mauer, Michael

AU - Nagai, Kojiro

AU - Tominaga, Tatsuya

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Diabetic nephropathy (DN) is the major cause of end-stage kidney disease, but early biomarkers of DN risk are limited. Herein we examine urinary IgG4 and Smad1 as additional early DN biomarkers. We recruited 815 patients with type 2 diabetes; 554 patients fulfilled the criteria of an estimated glomerular filtration rate (EGFR) >60 mL/min and no macroalbuminuria at baseline, with follow-up for 5 years. Patients without macroalbuminuria were also recruited for renal biopsies. Urinary IgG4 and Smad1 were determined by enzyme-linked immunoassays using specific antibodies. The specificity, sensitivity, and reproducibility were confirmed for each assay. Increased urinary IgG4 was significantly associated with lower EGFR. The level of urinary IgG4 also significantly correlated with surface density of peripheral glomerular basement membrane (Sv PGBM/Glom), whereas Smad1 was associated with the degree of mesangial expansion-both classic pathological findings in DN. Baseline EGFR did not differ between any groups; however, increases in both urinary IgG4 and Smad1 levels at baseline significantly predicted later development of EGFR decline in patients without macroalbuminuria. These data suggest that urinary IgG4 and Smad1 at relatively early stages of DN reflect underlying DN lesions and are relevant to later clinical outcomes.

AB - Diabetic nephropathy (DN) is the major cause of end-stage kidney disease, but early biomarkers of DN risk are limited. Herein we examine urinary IgG4 and Smad1 as additional early DN biomarkers. We recruited 815 patients with type 2 diabetes; 554 patients fulfilled the criteria of an estimated glomerular filtration rate (EGFR) >60 mL/min and no macroalbuminuria at baseline, with follow-up for 5 years. Patients without macroalbuminuria were also recruited for renal biopsies. Urinary IgG4 and Smad1 were determined by enzyme-linked immunoassays using specific antibodies. The specificity, sensitivity, and reproducibility were confirmed for each assay. Increased urinary IgG4 was significantly associated with lower EGFR. The level of urinary IgG4 also significantly correlated with surface density of peripheral glomerular basement membrane (Sv PGBM/Glom), whereas Smad1 was associated with the degree of mesangial expansion-both classic pathological findings in DN. Baseline EGFR did not differ between any groups; however, increases in both urinary IgG4 and Smad1 levels at baseline significantly predicted later development of EGFR decline in patients without macroalbuminuria. These data suggest that urinary IgG4 and Smad1 at relatively early stages of DN reflect underlying DN lesions and are relevant to later clinical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85046023764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046023764&partnerID=8YFLogxK

U2 - 10.2337/db17-1043

DO - 10.2337/db17-1043

M3 - Article

C2 - 29490904

AN - SCOPUS:85046023764

VL - 67

SP - 986

EP - 993

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -